蛋白质聚集竞争途径模型:膜结合蛋白的作用
Model for competing pathways in protein-aggregation: role of membrane bound proteins
摘要:
基于阿尔茨海默病中Aβ肽聚集的生物学重要性和复杂性,我们介绍了一种用于研究蛋白质聚集的模型和模拟方法,包括细胞外聚集、膜结合蛋白辅助的细胞表面聚集以及肽和蛋白质的供应、清除、产生和螯合。该模型用于生成聚集开始时的平衡和动力学聚集相图,以及由于聚集而降低的稳定Aβ单体浓度。我们实施的方法允许建模的现象,涉及数量级的时间尺度和浓度的差异,可以保留在模拟中。我们演示了如何确定的参数值范围,使单体浓度耗尽后,类似于在阿尔茨海默氏病中观察到的聚集。我们展示了如何非常不同的行为,可以得到反应参数和蛋白质浓度的变化,并讨论了调和实验结果从两个截然不同的浓度制度的困难。后者是一个重要的一般性问题,在有关体外和小鼠为基础的实验,以人类。
英文摘要:
Motivated by the biologically important and complex phenomena of Aβ peptide aggregation in Alzheimer's disease, we introduce a model and simulation methodology for studying protein aggregation that includes extra-cellular aggregation, aggregation on the cell-surface assisted by a membrane bound protein, and in addition, supply, clearance, production and sequestration of peptides and proteins. The model is used to produce equilibrium and kinetic-aggregation phase diagrams for aggregation onset and of reduced stable Aβ monomer concentrations due to aggregation. The methodology we implemented permits modeling of a phenomenon involving orders of magnitude differences in time scales and concentrations which can be retained in the simulation. We demonstrate how to identify ranges of parameter values that give monomer concentration depletion upon aggregation similar to that observed in Alzheimer's disease. We show how very different behavior can be obtained as reaction parameters and protein concentrations vary, and discuss the difficulty reconciling results of experiments from two vastly different concentration regimes. The latter is an important general issue in relating in-vitro and mice based experiments to humans.
机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。